A federal judge pressed both sides in a hearing on Wednesday questioning FDA approval of an abortion drug.
The case comes after the FDA recently expanded access to the drug regimen, allowing doctors to prescribe it via telehealth appointments for women to receive the abortion-inducing pills through the mail.
The lawsuit takes aim at the FDA’s decisions to loosen safety rules around prescribing the pill. It also contends that mifepristone, the first of the two drugs taken to cause an abortion, is not as safe as advertised and should not have even received FDA approval back in 2000.